Skip to main content
Livermore
Livermore
ZHEN

OrbiMed Advisors LLC

SEC CIK
0001055951
Latest filing
Aug 14, 2026

JANX holding history

Janux Therapeutics, Inc. in every 13F filed by OrbiMed Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

JANX overviewAll 13F holders of JANXFull Q2 2026 holdings

Shares (Q2 2026)
524,700
Value
$8.06M
% of portfolio
0.2%
Quarters held
21
Since Q2 2021
Holdings of JANX by OrbiMed Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026524,700$8.06M0.2%−458,900−46.7%ReducedHolders
Q1 2026983,600$13.7M0.3%−970,826−49.7%ReducedHolders
Q4 20251,954,426$27.0M0.6%+188,326+10.7%AddedHolders
Q3 20251,766,100$43.2M1.0%+555,800+45.9%AddedHolders
Q2 20251,210,300$28.0M0.7%+451,734+59.6%AddedHolders
Q1 2025758,566$20.5M0.5%00.0%UnchangedHolders
Q4 2024758,566$40.6M0.8%−500,000−39.7%ReducedHolders
Q3 20241,258,566$57.2M1.0%−1,721,262−57.8%ReducedHolders
Q2 20242,979,828$124.8M2.7%−1,295,725−30.3%ReducedHolders
Q1 20244,275,553$161.0M3.2%+957,626+28.9%AddedHolders
Q4 20233,317,927$35.6M0.7%00.0%UnchangedHolders
Q3 20233,317,927$33.4M0.8%+481,541+17.0%AddedHolders
Q2 20232,836,386$33.7M0.7%00.0%UnchangedHolders
Q1 20232,836,386$34.3M0.7%00.0%UnchangedHolders
Q4 20222,836,386$37.4M0.7%00.0%UnchangedHolders
Q3 20222,836,386$38.4M0.8%00.0%UnchangedHolders
Q2 20222,836,386$34.6M0.7%00.0%UnchangedHolders
Q1 20222,836,386$40.7M0.7%00.0%UnchangedHolders
Q4 20212,836,386$56.0M0.7%−630,000−18.2%ReducedHolders
Q3 20213,466,386$75.0M0.8%00.0%UnchangedHolders
Q2 20213,466,386$86.5M0.9%+3,466,386NewHolders